Health - The Purbottar

08 Aug

The COVID-19 vaccine developed by the Gamaleya centre will be registered on August 12

editor0 CommentsHealth

Amid the high number of coronavirus cases across the world, Russia is all set to register world's first COVID-19 vaccine next week, according to reports. The vaccine was developed by Gamaleya Research Institute and the Russian Defence Ministry. The vaccine will be registered on August 12. "The COVID-19 vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trials are extremely important. We have to understand that the vaccine must be safe. Medical professionals and senior citizens will be the first to get vaccinated," Gridnev told reporters, according…

06 Aug

A new infectious disease caused by a tick-borne virus has killed seven people and infected 60 others in China

editor0 CommentsHealth

A new infectious disease caused by a tick-borne virus has killed seven people and infected 60 others in China, official media here reported on Wednesday, warning about the possibility of its human-to-human transmission. More than 37 people in East China’s Jiangsu Province contracted with the SFTS Virus in the first half of the year. Later, 23 people were found to have been infected in East China’s Anhui province, state-run Global Times quoted media reports.

05 Aug

Sun Pharma launches FluGuard at Rs. 35/tab

editor0 CommentsBusiness, HealthSun Pharma

Sun Pharmaceutical Industries Limited announced that it has launched FluGuard (Favipiravir 200 mg) at an economical price of Rs. 35 per tablet, for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease. Commenting on the launch, Kirti Ganorkar, CEO of India Business, Sun Pharma said, “With over 50,000 Covid-19 cases being reported daily in India, there is an urgent need to provide more treatment options to healthcare professionals. We are launching FluGuard at an economical price to…

04 Aug

Vitamin C + Zinc tabs from Lincoln Pharma

editor0 CommentsHealth

In line with the company’s commitment towards ‘Healthcare for All’, Lincoln Pharmaceuticals Limited has launched chewable Vitamin C + Zinc tablet for the markets in India. The tablet is an evidence-based bio-active for natural immunity in a combination of zinc that boosts antiviral activity and protection against COVID 19. Mr Ashish R. Patel, Whole-Time Director, Lincoln Pharmaceuticals Limited, said, "During this COVID 19 Pandemic, immunity & immunity boosters are the only way to protect against the Virus. Vitamin-C & Zinc tablet has become a necessity and important part of all human being in their day to day life. With this…

02 Aug

Special milk that can prevent corona for only 20 rupees! Sales are booming in the state.

editor0 CommentsHealth

Special milk that can prevent corona for only 20 rupees! Sales are booming in the state.The Karnataka Milk Federation has claimed that milk is beneficial for boosting the immune system this time around.The Karnataka Milk Federation has claimed that milk is beneficial for boosting the immune system this time around. The company sells Tulsi-milk, milk with langar, Ashwagandha milk etc. The price is set at Rs 25 per 200 ml. But the sale is at 20 rupees.According to the Karnataka Milk Federation, no vaccine has yet been discovered in Corona. The only way is to increase immunity.In early June, the…

26 Jul

Amitabh Bachchan pens important post on alarming effects of COVID-19 on mental health.

editor0 CommentsHealth

Amitabh Bachchan pens important post on alarming effects of COVID-19 on mental health. Bollywood megastar Amitabh Bachchan, who has been undergoing treatment for COVID-19 at a hospital in Mumbai, has shared his thoughts about being in isolation for the past weeks and the effects it can have on the mental health of all those being treated for the same.In a blog post, highlighting the effects the disease can have on mental health, partly owing to the inability to be in contact with people. He said, “There is no one about or around .. and the freedom to be able to do that will extend…” Bachchan wrote…

24 Jul

Amway partners with FICCI for a webinar

editor0 CommentsBusiness, Healthamway

Amway India recently partnered with FICCI to host a webinar on Enabling Future Education in North East India. The virtual event was graced by Mr Jishnu Dev Varma, Deputy Chief Minister of Tripura, Mr TH. Radheshyam Singh, Minister of Education, Government of Manipur and Mr Ranjit Barthakur, Chairman of FICCI Northeast Advisory Council among others. Focused on making quality education accessible, the webinar addressed infrastructure requirements, the need for seamless integration of technology in the education system and identifying knowledge, skills, attitudes and values required to shape the future of students. Mr. Rajat Banerji, Vice-President - Corporate Affairs, Amway India,…

24 Jul

Favipiravir: Phase 3 Clinical Trial

editor0 CommentsHealthGlenmark

Top-line results from a Phase 3 clinical trial of Favipiravir in mild to moderate COVID-19 patients have been announced by Glenmark Pharmaceuticals Limited. The trial was conducted across seven clinical sites in India. The open-label randomized, multicenter clinical trial, conducted in 150 patients, evaluated the efficacy and safety of Favipiravir plus standard supportive care (Favipiravir treatment arm), versus standard supportive care alone (control arm), in mild to moderate patients, randomized within a 48 hour window of testing RT-PCR positive for COVID-19. Glenmark’s Favipiravir was well tolerated with no serious adverse events (SAEs) or deaths in the Favipiravir treated arm. 69.8%…

22 Jul

Glenmark’s response

editor0 CommentsBusiness, HealthGkenmark

In response to a letter regarding representation by a Member of Parliament, Mr Anurag Khera (Sr. Vice-president-Corporate Affairs) of Glenmark pharmaceuticals Limited sent a letter to Dr VG Somani, Director General of Health Services, Central Drugs Standard Control Organisation, clarifying its stand on the product Favipiravir tablets (200mg) manufactured and marketed by Glenmark that was granted permission by the latter’s office. Glenmark said, compared to other therapies approved for emergency use in COVID-19, Favipiravir (FabiFlu) is much more economical and an effective treatment option. The estimated total cost of therapy for full course with Favipiravir is Rs 9150, while Remdesivir,…

22 Jul

Almonds are a preferred snack

editor0 CommentsBusiness, HealthAlmomds

In today's fast-paced world, snacking has become an integral part of many Indians daily diet and routine. According to a recent survey conducted across 11 cities in India between 3 to 24 March by IPSOS, a research consulting firm, 91% of the participants try and opt for healthier alternatives whilst snacking. The survey by IPSOS aimed to identify the snacking habits and preferences amongst a group of people whose dietary preferences were divided into two categories - ‘vegetarian and non- vegetarian’. Overall, the results indicate that the participants across both categories prefer to snack on healthy and nutritious food items…